Index by author

October 01, 2020; Volume 87,Issue 10

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Aljadah, Michael M.
1. You have access
  Should we give triple therapy to patients with atrial fibrillation after percutaneous intervention?
  Asim Kichloo, MD, Michael M. Aljadah, MD, Farah Wani, MD and Sindhura Ananthaneni, MD
  
  Cleveland Clinic Journal of Medicine October 2020, 87 (10) 599-601; DOI: https://doi.org/10.3949/ccjm.87a.19115
  
  Triple therapy is aggressive and carries high risks of bleeding and death.
Ananthaneni, Sindhura
1. You have access
  Should we give triple therapy to patients with atrial fibrillation after percutaneous intervention?
  Asim Kichloo, MD, Michael M. Aljadah, MD, Farah Wani, MD and Sindhura Ananthaneni, MD
  
  Cleveland Clinic Journal of Medicine October 2020, 87 (10) 599-601; DOI: https://doi.org/10.3949/ccjm.87a.19115
  
  Triple therapy is aggressive and carries high risks of bleeding and death.
Augustine, Joshua
1. You have access
  COVID-19 and the kidney
  Mohamed Hassanein, MD, Yeshwanter Radhakrishnan, MD, John Sedor, MD, Tushar Vachharajani, MD, Vidula T. Vachharajani, MD, Joshua Augustine, MD, Sevag Demirjian, MD and George Thomas, MD
  
  Cleveland Clinic Journal of Medicine October 2020, 87 (10) 619-631; DOI: https://doi.org/10.3949/ccjm.87a.20072
  
  The kidney may be a target of SARS-CoV-2 infection.